Globally, almost 900 million adults are living with obesity
Dorothea Vafiadis , the National Council on Agings Senior Strategist for Healthy Aging, expects people to get stuck well before that
In the Flinders University study, of the 6954 women first prescribed GLP-1 receptor agonists during 2022, 90.5% did not have type 2 diabetes, suggesting that many were using the medication for weight loss
Masks : Indulge in nourishing, revitalizing skin treatments
A Network Meta-Analysis Comparing Tirzepatide and Semaglutide. February 11, 2026
A Quick Look at the Mechanism GLP-1 receptor agonists can help lower blood sugar and promote weight loss by mimicking a natural hormone that tells your body to release insulin, slow digestion, and reduce appetite